Halodine
About
Halodine is a biopharmaceutical company focused on the development of novel antiviral therapies. Halodine is a proprietary povidone-iodine antiseptic developed by leading clinicians for repeated nasal and oral administration. Halodine Nasal Antiseptic and Halodine Oral Rinse have been proven effective against SARS-CoV-2, the virus causing COVID-19, as well as other infections. Safe and easy-to-use, Halodine is designed to help protect hospitalized patients, health care personnel, and consumers. It was founded and is led by practicing MDs. Founded in 2020, the company is based in Miami, Florida.
Halodine is one of 2 Biopharma companies we track in South Florida.
Similar companies
View allADvantage TherapeuticsBiopharma | Est. 2021 | MIA | $21M |
Enalare TherapeuticsBiopharma | Est. 2019 | SWFL | $76M |
Kincell BioBiopharma | Est. 2023 | GNV | $58M |
Cadrenal TherapeuticsBiopharma | Est. 2022 | JAX | $20M |
Element SolutionsChemical | Est. 2019 | MIA | $950M |
Details
- Region
- South Florida / Miami
- City
- Miami
- Founded
- 2020
- Sector
- Biopharma
- Founders
- Kara Capriotti
- Website
- halodine.com
South Florida / Miami
South Florida anchors the state's fintech, crypto, and Latin America-facing economy, with a deep bilingual talent pool across Miami, Fort Lauderdale, and Palm Beach.